SCHEMBL5566781

SCHEMBL5566781

COc1cc2ncnc(Oc3cc(-c4ccccc4)[nH]n3)c2cc1OC

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.50
▸ KDR P35968 7/20 0.50
▸ LCK P06239 3/20 0.50
▸ RET P07949 2/20 0.50
▸ KIF5B P33176 1/20 0.50
▸ CSF1R P07333 3/20 0.49
▸ TRPA1 O75762 1/20 0.49
▸ BRAF P15056 1/20 0.47
▸ IRAK1 P51617 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ MET P08581 1/20 0.45
▸ PDGFRB P09619 1/20 0.45
▸ FLT4 P35916 1/20 0.45
▸ FLT3 P36888 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5565868 0.92 KDM1A (0.56) EGFRKDRLCKRETKIF5B
Hydrochloric Acid SCHEMBL5566986 0.91 KDM1A (0.55) EGFRKDRLCKRETKIF5B
SCHEMBL5566656 0.89 KDM1A (0.53) EGFRKDRLCKRETKIF5B
Hydrochloric Acid SCHEMBL5566338 0.88 KDM1A (0.52) EGFRKDRLCKRETKIF5B
SCHEMBL5565932 0.85 KDR (0.60) EGFRKDRLCKRETCSF1R
SCHEMBL7884841 0.85 KDM1A (0.41) EGFRKDRLCKRETKIF5B
SCHEMBL7885709 0.85 KDR (0.53) EGFRKDRLCKRETCSF1R
SCHEMBL5566917 0.84 EGFR (0.49) EGFRKDRCSF1RIRAK1IRAK4
Hydrochloric Acid SCHEMBL5566014 0.83 EGFR (0.48) EGFRKDRCSF1RIRAK1IRAK4
SCHEMBL5565918 0.83 SRC (0.57) EGFRKDRLCKRETMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119567-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2001-08-01 — — EP claimed
WO-2000021955-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-04-20 — — WO claimed
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 — — US disclosed
EP-1119567-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-05-04 — — EP disclosed
EP-1119567-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2001-08-01 — — EP disclosed
WO-2000021955-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-04-20 — — WO disclosed
Send feedback